EX-23.1 8 dex231.txt CONSENT OF INDEPENDENT ACCOUNTANTS Exhibit 23.1 CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS Hollis-Eden Pharmaceuticals, Inc. San Diego, California We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated January 19, 2001, relating to the financial statements of Hollis-Eden Pharmaceuticals, Inc. which is contained in that Prospectus. We also consent to the reference to us under the caption "Experts" in the Prospectus. /s/ BDO Seidman, LLP BDO Seidman, LLP New York, New York September 13, 2001